COVID-19 vaccine player AstraZeneca hands CEO $21.5M in pay for navigating pandemic

he decision to take AstraZeneca to the front lines of developing vaccines and drugs against COVID-19 has earned the British pharma global recognition—and CEO Pascal Soriot a big thank-you note.

AstraZeneca is handing Soriot £15.45 million ($21.52 million) in pay for delivering on financial and scientific goals in “extremely challenging circumstances” and for his “inspiring leadership” in the company’s COVID-19 response, AZ’s board said in its annual report.